StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioCorRx's revenue for the twelve months ending Sep 30, 2025 was $948.36K, up 3464.9% year over year. For fiscal 2025 it was $797.24K, up 10301.1% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is $1.17M in fiscal 2014.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$797.24K+10301.1%
FY2024Dec 31, 2024$7.67K-91.4%
FY2023Dec 31, 2023$89.16K-58.3%
FY2022Dec 31, 2022$213.84K+343.0%
FY2021Dec 31, 2021$48.27K-60.6%
FY2020Dec 31, 2020$122.62K-49.0%
FY2019Dec 31, 2019$240.26K-36.2%
FY2018Dec 31, 2018$376.66K-42.7%
FY2017Dec 31, 2017$657.27K-6.3%
FY2016Dec 31, 2016$701.77K-24.1%
FY2015Dec 31, 2015$924.73K-21.0%
FY2014Dec 31, 2014$1.17M+63.8%
FY2013Dec 31, 2013$714.96K-17.6%
FY2012Dec 31, 2012$868.16K+12.5%
FY2011Dec 31, 2011$771.76K+434.5%
FY2010Dec 31, 2010$144.40K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$87.97K-34.8%
Q1 FY2026Mar 31, 2026$214.54K–
Q3 FY2025Sep 30, 2025$635.22K–
Q2 FY2025Jun 30, 2025$178.24K+4306.4%
Q1 FY2025Mar 31, 2025$134.90K+3626.5%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$4.05K-79.4%
Q1 FY2024Mar 31, 2024$3.62K-91.0%
Q4 FY2023Dec 31, 2023$18.94K-7.7%
Q3 FY2023Sep 30, 2023$10.15K-58.7%
Q2 FY2023Jun 30, 2023$19.64K+93.9%
Q1 FY2023Mar 31, 2023$40.44K+82.0%
Q1 FY2022Mar 31, 2022$20.52K-31.2%
Q2 FY2021Sep 30, 2021$24.54K-27.2%
Q1 FY2021Mar 31, 2021$10.12K-72.6%
Q4 FY2020Dec 31, 2020$22.22K-64.4%
Q3 FY2020Sep 30, 2020$29.81K-36.0%
Q2 FY2020Jun 30, 2020$33.70K-48.9%
Q1 FY2020Mar 31, 2020$36.90K-43.5%
Q4 FY2019Dec 31, 2019$62.45K+20.8%
Q3 FY2019Sep 30, 2019$46.56K-40.8%
Q2 FY2019Jun 30, 2019$65.98K-33.1%
Q1 FY2019Mar 31, 2019$65.27K-55.8%
Q4 FY2018Dec 31, 2018$51.67K-68.7%
Q3 FY2018Sep 30, 2018$78.58K-46.8%
Q2 FY2018Jun 30, 2018$98.67K-53.1%
Q1 FY2018Mar 31, 2018$147.72K+10.1%
Q4 FY2017Dec 31, 2017$164.91K+42.3%
Q3 FY2017Sep 30, 2017$147.59K-11.9%
Q2 FY2017Jun 30, 2017$210.54K+12.0%
Q1 FY2017Mar 31, 2017$134.23K-41.7%
Q4 FY2016Dec 31, 2016$115.85K+58.1%
Q3 FY2016Sep 30, 2016$167.60K–
Q2 FY2016Jun 30, 2016$187.91K–
Q1 FY2016Mar 31, 2016$230.41K–
Q4 FY2015Dec 31, 2015$73.30K–

More BioCorRx figures

See a number that looks wrong?